Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gastrin-releasing peptide receptor (GRPR) is a G protein-coupled receptor that mediates the effects of gastrin-releasing peptide (GRP) in the central nervous system and peripheral tissues. It plays a role in regulating gastrointestinal function, modulating immune responses, and influencing neurological processes. GRPR is overexpressed in several malignancies, making it an attractive target for imaging and therapy in oncology. It is also implicated in neurological disorders, itch transmission, and inflammation.
GRPR activation by agonists leads to stimulation of the phospholipase C pathway via Gq proteins, increasing intracellular calcium levels and downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrin-releasing peptide receptor (GRPR).